JAMA Clinical Reviews
Coronavirus (COVID-19) Update: Chloroquine/Hydroxychloroquine and Azithromycin
Mar 24, 2020 · 17 min
Play episode

Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug's potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto.

More episodes from JAMA Clinical Reviews
Search
Clear search
Close search
Google apps
Main menu